Anpario plc (FRA:KI9A)

Market Cap	117.54M +35.2%
Revenue (ttm)	54.08M +23.5%
Net Income	7.74M +64.2%
EPS	0.43 +55.4%
Shares Out	n/a
PE Ratio	15.19
Forward PE	14.16
Dividend	0.13 (2.47%)
Ex-Dividend Date	Nov 13, 2025

Volume	n/a
Average Volume	99
Open	5.45
Previous Close	5.50
Day's Range	5.30 - 5.45
52-Week Range	4.12 - 7.00
Beta	n/a
RSI	53.05
Earnings Date	Mar 31, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Food and Kindred Products
• Founded: 1996
• Employees: 162
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KI9A

Financial Performance

In 2025, Anpario's revenue was 47.18 million, an increase of 23.51% compared to the previous year's 38.20 million. Earnings were 6.75 million, an increase of 64.20%.

Financial numbers in GBP